A citation-based method for searching scientific literature

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
Times Cited: 143



Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J Gilbert, Thomas Helbich, Sylvia H Heywang-Köbrunner, Werner A Kaiser, Michael J Kerin, Robert E Mansel, Lorenza Marotti, Laura Martincich, Louis Mauriac, Hanne Meijers-Heijboer, Roberto Orecchia, Pietro Panizza, Antonio Ponti, Arnie D Purushotham, Peter Regitnig, Marco Rosselli Del Turco, Fabienne Thibault, Robin Wilson. Eur J Cancer 2010
Times Cited: 537




List of shared articles



Times cited

Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer.
Fabian Tollens, Pascal A T Baltzer, Matthias Dietzel, Moritz L Schnitzer, Vincent Schwarze, Wolfgang G Kunz, Johann Rink, Johannes Rübenthaler, Matthias F Froelich, Stefan O Schönberg,[...]. Eur Radiol 2022
0

Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.
Natsuko Onishi, Masako Kataoka. Breast Cancer 2021
2

Cost-effectiveness of MR-mammography vs. conventional mammography in screening patients at intermediate risk of breast cancer - A model-based economic evaluation.
Clemens G Kaiser, Matthias Dietzel, Tibor Vag, Matthias F Froelich. Eur J Radiol 2021
9

Impact of specificity on cost-effectiveness of screening women at high risk of breast cancer with magnetic resonance imaging, mammography and ultrasound.
Clemens G Kaiser, Matthias Dietzel, Tibor Vag, Johannes Rübenthaler, Matthias F Froelich, Fabian Tollens. Eur J Radiol 2021
2

MRI versus Mammography plus Ultrasound in Women at Intermediate Breast Cancer Risk: Study Design and Protocol of the MRIB Multicenter, Randomized, Controlled Trial.
Luigina Ada Bonelli, Massimo Calabrese, Paolo Belli, Stefano Corcione, Claudio Losio, Stefania Montemezzi, Federica Pediconi, Antonella Petrillo, Chiara Zuiani, Lucia Camera,[...]. Diagnostics (Basel) 2021
0

Gadolinium Retention and Breast MRI Screening: More Harm Than Good?
Francesco Sardanelli, Andrea Cozzi, Rubina Manuela Trimboli, Simone Schiaffino. AJR Am J Roentgenol 2020
13

Screening in patients with increased risk of breast cancer (part 1): pros and cons of MRI screening.
S Alonso Roca, A B Delgado Laguna, J Arantzeta Lexarreta, B Cajal Campo, S Santamaría Jareño. Radiologia (Engl Ed) 2020
1

Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study.
Francesco Sardanelli, Rubina M Trimboli, Nehmat Houssami, Fiona J Gilbert, Thomas H Helbich, Marina Alvarez Benito, Corinne Balleyguier, Massimo Bazzocchi, Peter Bult, Massimo Calabrese,[...]. Eur Radiol 2020
9

Screening in patients with increased risk of breast cancer (part 2). Where are we now? Actual MRI screening controversies.
S Alonso Roca, A B Delgado Laguna, J Arantzeta Lexarreta, B Cajal Campo, A López Ruiz. Radiologia (Engl Ed) 2020
1

Breast ultrasonography (BU) in the screening protocol for women at hereditary-familial risk of breast cancer: has the time come to rethink the role of BU according to different risk categories?
Laura Cortesi, Barbara Canossi, Rachele Battista, Annarita Pecchi, Antonella Drago, Chiara Dal Molin, Angela Toss, Elisabetta De Matteis, Isabella Marchi, Pietro Torricelli,[...]. Int J Cancer 2019
12

Abbreviated MRI of the Breast: Does It Provide Value?
Doris Leithner, Linda Moy, Elizabeth A Morris, Maria A Marino, Thomas H Helbich, Katja Pinker. J Magn Reson Imaging 2019
38

Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T.
Paola Clauser, Thomas H Helbich, Panagiotis Kapetas, Katja Pinker, Maria Bernathova, Ramona Woitek, Andreas Kaneider, Pascal A T Baltzer. J Magn Reson Imaging 2019
5

Can we predict lesion detection rates in second-look ultrasound of MRI-detected breast lesions? A systematic analysis.
Alexander Bumberger, Paola Clauser, Michael Kolta, Panagiotis Kapetas, Maria Bernathova, Thomas H Helbich, Katja Pinker, Pascal A Baltzer. Eur J Radiol 2019
9

Does higher field strength translate into better diagnostic accuracy? A prospective comparison of breast MRI at 3 and 1.5 Tesla.
Matthias Dietzel, Evelyn Wenkel, Matthias Hammon, Paola Clauser, Michael Uder, Rüdiger Schulz-Wendtland, Pascal A T Baltzer. Eur J Radiol 2019
7

A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice.
Paola Clauser, Ritse Mann, Alexandra Athanasiou, Helmut Prosch, Katja Pinker, Matthias Dietzel, Thomas H Helbich, Michael Fuchsjäger, Julia Camps-Herrero, Francesco Sardanelli,[...]. Eur Radiol 2018
52

The frequency of missed breast cancers in women participating in a high-risk MRI screening program.
S Vreemann, A Gubern-Merida, S Lardenoije, P Bult, N Karssemeijer, K Pinker, R M Mann. Breast Cancer Res Treat 2018
15

MRI-based quantification of residual fibroglandular tissue of the breast after conservative mastectomies.
Ramona Woitek, Georg Pfeiler, Alex Farr, Panagiotis Kapetas, Julia Furtner, Maria Bernathova, Veronika Schöpf, Paola Clauser, Maria A Marino, Katja Pinker,[...]. Eur J Radiol 2018
14


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy